Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02907918
Title Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer (PALTAN)
Acronym PALTAN
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.